Annotation Detail for MYBPC3

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| hsa05410 | Hypertrophic cardiomyopathy (HCM) |
| hsa05414 | Dilated cardiomyopathy |
| Pathway ID | Pathway Name |
|---|
| Muscle contraction |
| Desease ID | Desease Name |
|---|
| Circulatory system diseases |
| Cardiac diseases |
| H00294 | Dilated cardiomyopathy (DCM) |
| H00292 | Hypertrophic cardiomyopathy (HCM) |
| Desease ID | Desease Name |
|---|
| 2075 | Heart failure |
| Desease Name |
|---|
| CARDIOVASCULAR |
| cardiomyopathy |
| familial hypertrophic cardiomyopathy. |
| Desease Name |
|---|
| Cardiomyopathy, familial hypertrophic, 4 |
| Cardiomyopathy, dilated |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of MYBPC3 mRNA | decreases expression | 18175754
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D009202 |
Cardiomyopathies |
marker/mechanism |
|
| 19151713 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
marker/mechanism |
|
| |
| OMIM:115197 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4 |
marker/mechanism |
|
| |
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.66 | 15894690 |
| MESH:D016757 |
Death, Sudden, Cardiac |
marker/mechanism |
|
| 20435227 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.30 | 16285004 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.39 | 15131321 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.60 | 14714311 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.76 | 14737004 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.32 | 18760546 |
PharmGKB Accession:PA31351
| Releated disease ID |
Related disease Name |
| PA445018 | Cardiomyopathies |